Please login to the form below

Not currently logged in
Email:
Password:

Sanofi invests €20m in Morocco

Will also collaborate with government on diabetes, mental health, epilepsy and pharma training

Sanofi invests €20m in Morocco

Sanofi has reinforced its presence in North Africa with a €20m investment in Morocco.

The France-based pharma company opened a logistics hub in Casablanca, which is set to become the largest distribution centre for Sanofi's medicines in Africa.

It will handle 1,300 product produced by Sanofi's Moroccan subsidiary Sanofi-Aventis Maroc, with these set for use either in Morocco and for exportation to sub-Saharan Africa.

The hub adds to Sanofi's existing operations in the country, which comprises a workforce of 900 people and facilities, such as the Maphar production site in Zenata, Casablanca.

Government collaborations
In addition to the new logistics centre, Sanofi also announced it was collaborating with Morocco's government in three priority healthcare areas.

The company will work with both the Ministry of Industry and the Ministry of Health to improve care for patients with type 1 diabetes; patients with mental health conditions and epilepsy; and to provide training for a career in the pharma industry.

The diabetes agreement is set to last three years and will involved Sanofi-Aventis Maroc and the Ministry of Health collaborating to develop standard care protocols for children and young people with diabetes.

This will include a standardised therapeutic education programme and the creation of two new diabetes paediatric centres in Oujda and Agadir, adding to the existing 11 centres in the country.

The mental health and epilepsy collaboration also involves Sanofi-Aventis Maroc and the Ministry of Health, and aims to provide trainining on these conditions for 40 psychiatrists, 40 neurologists, 160 GPs and 160 nurses. There will also be a campaign to raise awareness of these condtions among the Moroccan population.

The third agreement involves the Ministry of Trade, Industry and New Technologies, which will work with its health counterpart and Sanofi to create a general framework for the development of the Moroccan pharmaceutical industry.

Specifically, Sanofi's involvement will feature training on the pharma industry for agents, technicians and managers working in the Ministry of Health.

Sanofi's CEO Christopher Viehbacher, who opened the new site in Morocco, said: "As medicines alone cannot fight such diseases as diabetes, mental disorders and epilepsy, the collaborations signed today reinforce Sanofi's commitment in building major programmes with stakeholders in the public and private sectors to provide solutions for prevention, awareness and diagnosis for the benefit of patients."

18th April 2013

From: Sales, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics